comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 21:05:23 - browse：26

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Traditional Chinese medicine benefits explored in new JAMA study

hotspot

WSS

Why Sanofi got shellacked over its spinoff

GSK Flovent asthma inhalers replaced by authorized generics

Physician subsidies by hospitals soar in wake of No Surprises Act

Paying for Covid pills will soon shift to insurers

Feng Zhang CRISPR delivery startup lays off quarter of staff

Emergency medicine has repudiated 'excited delirium.' Now what?

hotspot

comprehensive

hotspot

Medical records are filled with copy

Ahead of JPM, here's who's profiting most in health care

Alkermes shareholders re

Emergency medicine has repudiated 'excited delirium.' Now what?

Medicare details structure of new drug price negotiation program

3 trends to watch in health tech's hiring outlook for 2024

Sports medicine is finally prioritizing gender equality

Feng Zhang, Grail founder join forces on new gene editing startup

The high cost of giving birth even with insurance

Paying for Covid pills will soon shift to insurers

leisure time

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Federal weight loss drug coverage is 30 years out of date

FDA has safety concerns on CRISPR

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

hotspot

focus

hotspot

knowledge